PPC history of obesity treatment  

Meso therapy -  PPC therapy - LLD therapy  - PLD therapy 


 

PLD Therapy     Phosphatidyl-assisted Lymphatic Drainage
 

First developed as a drug for the fat embolism in Russia in 1959

Presented at the 5th International Mesotherapy Society held in Paris

in 1988 by the Italian physician Dr. Sergio Maggiori

Injection to obtain a therapeutic effect for topical obesity

by destruction of fat cells, size reduction and skin lifting effect

Since the late 1990s, widely used for the treatment of obesity

in the United States, South America and Europe etc.

In 1950’s widely used as a subcutaneous injection

Pharmacological fuctions

     - Eliminate the barriers between organizations

     - Reduce hyperplasia of the the fiber

     - Reduce the swelling and edema of the organization

Recently adaptation range

    -  Prevent and remove swelling and bruising after surgery

-  Distribution of body fluids such as hematoma removal

-  Prevent peritoneal adhesions

-  Reduction of fibrous tissue proliferation and ease of peeling

   à Usefully used as interventional pain care  

 

LLD refers to lymph circulation fat melting treatment.

By injecting Hyaluronidase directly into the subcutaneous fat to  

destroy cellulite, and the fat cells smoothly move into lymph fluid

through the lymphatic massage.  Improve the flow of lymph fluid by

destroying  the fat cells and the destroyed fat cells are  drawed off fast

through the lymphatic vessel. So this will help the body modification  

the fundamental cause of obesity. 

The only authorized PPC as medicine